Immunity and HER2-positive disease: never stop questioning
Ann Oncol
.
2015 Dec;26(12):2361-2.
doi: 10.1093/annonc/mdv497.
Epub 2015 Oct 20.
Author
S Loi
1
Affiliation
1
Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia sherene.loi@petermac.org.
PMID:
26487579
DOI:
10.1093/annonc/mdv497
No abstract available
Publication types
Editorial
Comment
MeSH terms
Breast Neoplasms / immunology*
Humans
Receptor, ErbB-2 / immunology*
Substances
Receptor, ErbB-2